National Clinical trials for osteosarcoma

Solid Tumor Clinical trials at mgh boston

Gemcitabine for osteosarcoma at dana-farber

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

 

Clinical Trial Description

Phase Ib/IIa Study of SLIT^TM Cisplatin by Inhalation in the Treatment of Patients with Relapsed/Progressive Osteosarcoma Metastatic to the Lung

Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma

Gemcitabine and Docetaxel in Treating Patients With Recurrent Osteosarcoma or Ewing's Sarcoma or Unresectable or Locally Recurrent Chondrosarcoma

A Phase I Trial of 17-AAG in Patients with Recurrent/Refractory Pediatric Solid Tumors and Leukemia

Phase II Study of Chemotherapy and Pamidronate for the Treatment of Newly Diagnosed Osteosarcoma
Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma

Phase II Study of Paclitaxel (Taxol) in Patients with Refractory Osteosarcoma and Its Variants (Summary Last Modified 09/94)

A Phase I Trial of 17-AAG in Patients with Recurrent/Refractory Pediatric Solid Tumors and Leukemia

Low level of participation in clinical trials of young adults with bone cancer

Clinical Applications of Cytokines and Growth Factors (Developments in Oncology)

Experimental Treatments? Unapproved But Not Always Unavailable